Lincoln Pharmaceuticals Ltd Share Price
(LINCOLN)
₹554.75▲2.74%
as on 04:01PM, 19 Mar 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -5.46 % |
3 Month Return | -33.63 % |
1 Year Return | -6.3 % |
Market Stats | |
Previous Close | ₹539.95 |
Open | ₹548.60 |
Volume | 59.53K |
Upper Circuit | ₹647.90 |
Lower Circuit | ₹432.00 |
Market Cap | ₹1,081.51Cr |
P/E Ratio
12.1
PEG Ratio
11.52
Market Cap
₹1,081.51 Cr
P/B Ratio
1.98
EPS
46.58
Dividend Yield
0.31
Sector
Pharmaceuticals
ROE
17.04
Lincoln Pharmaceuticals Surges 7.83% on December 30 - 30 Dec, 2024
Lincoln Pharmaceuticals Hits Upper Circuit with Strong Performance - 03 Dec, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, LINCOLN stock has moved up by 2.5%
Retail Holding Up
Retail Investor have increased holdings from 45.03% to 45.06% in Dec 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 49.78% of holdings in Dec 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 67.5% return, outperforming this stock by 73.8%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 126.9% return, outperforming this stock by 67.4%
Revenue Fall
Revenue is down for the last 2 quarters, 171.19 Cr → 155.52 Cr (in ₹), with an average decrease of 9.2% per quarter
Profit Down
Netprofit is down for the last 2 quarters, 26.33 Cr → 20.77 Cr (in ₹), with an average decrease of 21.1% per quarter
FII Holding Down
Foreign Institutions have decreased holdings from 5.19% to 5.16% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 49.78% | 0.00 | |
Foreign Institutions | 5.16% | ||
Mutual Funds | 0% | 38.46 | |
Retail Investors | 45.06% | 0.07 | |
Others | 0% |
Lincoln Pharmaceuticals Ltd in the last 5 years
Lowest (3.58x)
March 23, 2020
Today (12.10x)
March 18, 2025
Industry (51.23x)
March 18, 2025
Highest (19.77x)
December 9, 2024
Lincoln Pharmaceuticals Ltd’s net profit fell -25.93% since last year same period to ₹20.77Cr in the Q3 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -21.12% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Lincoln Pharmaceuticals Ltd has declared dividend of ₹1.80 - translating a dividend yield of 0.59%.
Read More about DividendsBearish
Neutral
Bullish
Lincoln Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹1,081.51 Cr | 94.15% | 0.50 | ₹93 Cr | ₹580 Cr | |
NA | ₹47.23 Cr | 12.95% | 0.68 | NA | NA | |
NA | ₹115.89 Cr | 84.64% | 0.50 | NA | NA | |
NA | ₹1,439.94 Cr | 549.29% | 0.52 | NA | NA | |
NA | ₹21.77 Cr | 25.86% | 0.52 | NA | NA |
Organisation | Lincoln Pharmaceuticals Ltd |
Headquarters | Ahmedabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Lincoln Pharmaceuticals Ltd share price today stands at ₹554.75, Open: ₹548.6, Previous Close: ₹539.95, High: ₹563.95, Low: ₹542.8, 52 Week High: ₹979.5, 52 Week Low: ₹499.
Today's traded volume of Lincoln Pharmaceuticals Ltd(LINCOLN) is 59.53K.
Today's market capitalisation of Lincoln Pharmaceuticals Ltd(LINCOLN) is ₹1081.51Cr.
Lincoln Pharmaceuticals Ltd (LINCOLN) share price is ₹554.75. It is down -43.36% from its 52 Week High price of ₹979.5
Lincoln Pharmaceuticals Ltd (LINCOLN) share price is ₹554.75. It is up 11.17% from its 52 Week Low price of ₹499